- A novel irreversible TEAD inhibitor, SWTX-143, blocks Hippo pathway transcriptional output and causes tumor regression in preclinical mesothelioma models.(2023)
Authors: Hanne Hillen, Weronika Kowalczyk, Patrick Chaltin, Georg Halder
Pages: OF1 - OF11
- In vivo effects of novel YAP/TAZ-TEAD inhibitors(2023)
Authors: Hanne Hillen, Georg Halder
- Hippo signaling instructs ectopic but not normal organ growth(2022)
Authors: Weronika Kowalczyk, Hanne Hillen, Jun Xie, Soheil Soheily, Ivan Moya, Stein Aerts, Georg Halder
Pages: 744 - +
- Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis(2021)
Authors: Elisabeth Verboven, Ivan Moya, Jun Xie, Hanne Hillen, Weronika Kowalczyk, Gerlanda Vella, Stephanie Castaldo, Soheil Soheily, Diether Lambrechts, Tania Roskams, et al.
Pages: 847 - 862
- Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice(2019)
Authors: Ivan Moya, Stephanie Castaldo, Soheil Soheily, Jun Xie, Elisabeth Verboven, Hanne Hillen, Ruçhan Karaman, Matthias Van Haele, Weronika Kowalczyk, Panagiotis Karras, et al.
Pages: 1029 - 1034